đź“‹ FDA Reference
philips ct secura mv
Philips Medical Systems North America
Summary: The Philips CT Secura MV is a computed tomography (CT) scanner used for detailed imaging in various medical settings. It is primarily used by radiologists and healthcare professionals for diagnostic purposes.
FDA Clearance Information
Pathway
510K
Number
K000819 ↗
Decision Date
May 12, 2000
Product Code
JAK
Device Class
Class 2
Evidence
419 studies
The Philips CT Secura MV was cleared via the FDA 510k pathway on May 12, 2000. Manufactured by Philips Medical Systems North America, it is classified as a Class 2 device under product code JAK.
What It Is
The Philips CT Secura MV is a medical imaging device that uses computed tomography to create detailed cross-sectional images of the body. It operates by rotating an X-ray source and detectors around the patient, capturing data that is processed into images by a computer. This device is crucial for diagnosing a variety of conditions, providing high-resolution images that help in assessing internal structures.
Clinical Applications
The Philips CT Secura MV is commonly used in hospitals and diagnostic centers for a range of clinical applications, including evaluating trauma patients, detecting tumors, and guiding biopsies. It is particularly valuable in emergency medicine, oncology, and neurology. The device is suitable for both adult and pediatric patients, offering versatility in imaging different anatomical regions.
Indications for Use
The FDA-cleared indications for the Philips CT Secura MV include its use in diagnostic imaging to assist in the evaluation of various medical conditions. It is designed to provide detailed images that help clinicians in diagnosing diseases and planning treatments.
Practical Considerations
When using the Philips CT Secura MV, consider the compatibility with existing imaging protocols and the need for contrast agents in certain studies. The device typically accommodates a range of patient sizes, but positioning and technique may vary based on the specific clinical scenario.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is Philips CT Secura MV used for?
The Philips CT Secura MV is used for creating detailed cross-sectional images of the body to assist in diagnosing medical conditions.
What specialties typically use this device?
Radiologists, emergency medicine physicians, oncologists, and neurologists commonly use this device for diagnostic imaging.
What are the FDA-cleared indications?
The device is indicated for use in diagnostic imaging to evaluate a variety of medical conditions, providing detailed images for clinical assessment.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.